Preclinical studies using in vitro multiple RCC cells and in vivo mouse model all demonstrated P2RX6 might function via ATP-P2RX6-Ca2+ −p-ERK1/2-MMP9 axis to drive RCC cells invasion and metastasis. The gene discussed is MMP9; the disease is renal cell carcinoma.